Non-corticosteroid treatment for nephrotic syndrome in children (Q24246970)

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Cyclosporin in the treatment of idiopathic nephrotic syndrome in children.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Intravenous immunoglobulin in minimal change nephrotic syndrome: a crossover trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Side effects of levamisole in children with nephrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Randomized versus historical controls for clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Chlorambucil dosage in frequently relapsingnephrotic syndrome: A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

164 children with nephrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Sterility and testicular atrophy related to cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Cyclophosphamide and the pubertal testis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Chlorambucil treatment of frequently relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Concomitant administration of cyclosporine and ketoconazole in idiopathic nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Controlled trial of disodium cromoglycate in prevention of relapse of steroid-responsive nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Long-term outcome of primary nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Eight and 12 week courses of cyclophosphamide in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Report of a Workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

Unconjugated hyperbilirubinemia due to ciclosporin administration in children with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB2

7 January 2021

10.1002/14651858.CD002290.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

527744

OpenCitations bibliographic resource ID

527744

1 reference